Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with vitamin B6 deficiency

Chi Fen Chen, Tsan Zon Liu, Wu Hsiang Lan, Li An Wu, Chin Hung Tsai, Jeng Fong Chiou, Li Yu Tsai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A novel spectrophotometric method for the quantification of urinary xanthurenic acid (XA) is described. The direct acid ferric reduction (DAFR) procedure was used to quantify XA after it was purified by a solid-phase extraction column. The linearity of proposed method extends from 2.5 to 100.0 mg/L. The method is precise, yielding day-to-day CVs for two pooled controls of 3.5% and 4.6%, respectively. Correlation studies with an established HPLC method and a fluorometric procedure showed correlation coefficients of 0.98 and 0.98, respectively. Interference from various urinary metabolites was insignificant. In a small-scale screening of elderly conducted at Penghu county in Taiwan (n = 80), we were able to identify a group of twenty individuals having hyperhomocysteinemia (>15 mole/L). Three of them were found to be positive for XA as analyzed by the proposed method, which correlated excellently with the results of the activation coefficient method for RBC's AST/B6 functional test. These data confirm the usefulness of the proposed method for identifying urinary XA as an indicator of vitamin B6 deficiency-associated hyperhomocysteinemic condition.

Original languageEnglish
Article number678476
JournalBioMed Research International
Volume2013
DOIs
Publication statusPublished - 2013

Fingerprint

Vitamin B 6 Deficiency
Hyperhomocysteinemia
Vitamin B 6
Metabolites
Screening
Chemical activation
Acids
xanthurenic acid
Solid Phase Extraction
Taiwan
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with vitamin B6 deficiency. / Chen, Chi Fen; Liu, Tsan Zon; Lan, Wu Hsiang; Wu, Li An; Tsai, Chin Hung; Chiou, Jeng Fong; Tsai, Li Yu.

In: BioMed Research International, Vol. 2013, 678476, 2013.

Research output: Contribution to journalArticle

@article{72b0e89678f442f59c16789e0e664595,
title = "Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with vitamin B6 deficiency",
abstract = "A novel spectrophotometric method for the quantification of urinary xanthurenic acid (XA) is described. The direct acid ferric reduction (DAFR) procedure was used to quantify XA after it was purified by a solid-phase extraction column. The linearity of proposed method extends from 2.5 to 100.0 mg/L. The method is precise, yielding day-to-day CVs for two pooled controls of 3.5{\%} and 4.6{\%}, respectively. Correlation studies with an established HPLC method and a fluorometric procedure showed correlation coefficients of 0.98 and 0.98, respectively. Interference from various urinary metabolites was insignificant. In a small-scale screening of elderly conducted at Penghu county in Taiwan (n = 80), we were able to identify a group of twenty individuals having hyperhomocysteinemia (>15 mole/L). Three of them were found to be positive for XA as analyzed by the proposed method, which correlated excellently with the results of the activation coefficient method for RBC's AST/B6 functional test. These data confirm the usefulness of the proposed method for identifying urinary XA as an indicator of vitamin B6 deficiency-associated hyperhomocysteinemic condition.",
author = "Chen, {Chi Fen} and Liu, {Tsan Zon} and Lan, {Wu Hsiang} and Wu, {Li An} and Tsai, {Chin Hung} and Chiou, {Jeng Fong} and Tsai, {Li Yu}",
year = "2013",
doi = "10.1155/2013/678476",
language = "English",
volume = "2013",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with vitamin B6 deficiency

AU - Chen, Chi Fen

AU - Liu, Tsan Zon

AU - Lan, Wu Hsiang

AU - Wu, Li An

AU - Tsai, Chin Hung

AU - Chiou, Jeng Fong

AU - Tsai, Li Yu

PY - 2013

Y1 - 2013

N2 - A novel spectrophotometric method for the quantification of urinary xanthurenic acid (XA) is described. The direct acid ferric reduction (DAFR) procedure was used to quantify XA after it was purified by a solid-phase extraction column. The linearity of proposed method extends from 2.5 to 100.0 mg/L. The method is precise, yielding day-to-day CVs for two pooled controls of 3.5% and 4.6%, respectively. Correlation studies with an established HPLC method and a fluorometric procedure showed correlation coefficients of 0.98 and 0.98, respectively. Interference from various urinary metabolites was insignificant. In a small-scale screening of elderly conducted at Penghu county in Taiwan (n = 80), we were able to identify a group of twenty individuals having hyperhomocysteinemia (>15 mole/L). Three of them were found to be positive for XA as analyzed by the proposed method, which correlated excellently with the results of the activation coefficient method for RBC's AST/B6 functional test. These data confirm the usefulness of the proposed method for identifying urinary XA as an indicator of vitamin B6 deficiency-associated hyperhomocysteinemic condition.

AB - A novel spectrophotometric method for the quantification of urinary xanthurenic acid (XA) is described. The direct acid ferric reduction (DAFR) procedure was used to quantify XA after it was purified by a solid-phase extraction column. The linearity of proposed method extends from 2.5 to 100.0 mg/L. The method is precise, yielding day-to-day CVs for two pooled controls of 3.5% and 4.6%, respectively. Correlation studies with an established HPLC method and a fluorometric procedure showed correlation coefficients of 0.98 and 0.98, respectively. Interference from various urinary metabolites was insignificant. In a small-scale screening of elderly conducted at Penghu county in Taiwan (n = 80), we were able to identify a group of twenty individuals having hyperhomocysteinemia (>15 mole/L). Three of them were found to be positive for XA as analyzed by the proposed method, which correlated excellently with the results of the activation coefficient method for RBC's AST/B6 functional test. These data confirm the usefulness of the proposed method for identifying urinary XA as an indicator of vitamin B6 deficiency-associated hyperhomocysteinemic condition.

UR - http://www.scopus.com/inward/record.url?scp=84885602028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885602028&partnerID=8YFLogxK

U2 - 10.1155/2013/678476

DO - 10.1155/2013/678476

M3 - Article

C2 - 24151616

AN - SCOPUS:84885602028

VL - 2013

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 678476

ER -